These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene. Myerowitz R Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523 [TBL] [Abstract][Full Text] [Related]
6. Tay-Sachs disease in persons of French-Canadian heritage in northern New England. Palomaki GE; Williams J; Haddow JE; Natowicz MR Am J Med Genet; 1995 May; 56(4):409-12. PubMed ID: 7604851 [TBL] [Abstract][Full Text] [Related]
8. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960 [TBL] [Abstract][Full Text] [Related]
9. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system. Miklyaeva EI; Dong W; Bureau A; Fattahie R; Xu Y; Su M; Fick GH; Huang JQ; Igdoura S; Hanai N; Gravel RA Brain Res; 2004 Mar; 1001(1-2):37-50. PubMed ID: 14972652 [TBL] [Abstract][Full Text] [Related]
10. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program. Rozenberg R; Pereira Lda V Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789 [TBL] [Abstract][Full Text] [Related]
11. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued? Zlotogora J; Leventhal A Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764 [TBL] [Abstract][Full Text] [Related]
12. The cherry-red spot in Tay-Sachs and other storage diseases. Kivlin JD; Sanborn GE; Myers GG Ann Neurol; 1985 Apr; 17(4):356-60. PubMed ID: 4004157 [TBL] [Abstract][Full Text] [Related]
13. [Tay-Sachs disease: a case report]. Koch S; Widhalm K Padiatr Padol; 1991; 26(6):275-8. PubMed ID: 1838805 [TBL] [Abstract][Full Text] [Related]
14. Tay-Sach disease with "cherry-red spot"--first reported case in Malaysia. Chan LY; Balasubramaniam S; Sunder R; Jamalia R; Karunakar TV; Alagaratnam J Med J Malaysia; 2011 Dec; 66(5):497-8. PubMed ID: 22390110 [TBL] [Abstract][Full Text] [Related]
15. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Navon R; Proia RL Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679 [TBL] [Abstract][Full Text] [Related]
16. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493 [TBL] [Abstract][Full Text] [Related]
17. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel. Broide E; Zeigler M; Eckstein J; Bach G Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907 [TBL] [Abstract][Full Text] [Related]
18. Ultrastructural pathology of skin biopsy and fibroblast enzyme studies in a case of GM2-gangliosidosis with deficient hexosaminidase A and thermolabile hexosaminidase B. Burck U; Harzer K; Goebel HH; Elze KL; Held KR; Carstens L Neuropadiatrie; 1980 May; 11(2):161-75. PubMed ID: 6255371 [TBL] [Abstract][Full Text] [Related]